As Manipal Hospitals expands globally, its legacy of clinical excellence and dedicated care is best captured in real patient stories. The journey of Mohammed Rafi, a 41-year-old Bengaluru resident, epitomizes the hospital’s expertise in handling rare, complex cardiac cases and highlights why patients from around the globe can confidently choose Manipal Hospitals for their advanced care.
Patient Background
For 18 long years, life for 41-year-old Mohammed Rafi, a marketing manager from Kerala residing in Bengaluru, was a constant battle against a failing heart. Diagnosed in his early twenties with Hypertrophic Cardiomyopathy (HCM)—a rare, genetically inherited heart condition—his life took an unexpected turn from being an active young man who loved cricket to someone struggling daily for survival.
Tragically, HCM ran deeply in his family, claiming the life of his young daughter at just four years old and affecting multiple relatives including his mother, sister, and grandmother. Rafi knew that unless treated decisively, he too risked the same fate.
This narrative mirrors challenges faced by many international patients: hereditary diseases often undiagnosed until advanced stages, limited access to specialized genetic screening abroad, high costs of transplants, and cultural/language barriers in seeking care overseas. For patients from regions like the UAE or Southeast Asia, where genetic cardiac disorders are prevalent but expertise is scarce, such delays can be life-threatening.
The Turning Point in Rafi’s Life
Rafi’s condition worsened over time. Simple activities became monumental tasks—pushing his bike through traffic, lifting his laptop, or even walking without fatigue. His heart condition advanced to the stage of heart failure.
Despite receiving supportive care, including the implantation of an Automated Implantable Cardioverter Defibrillator (AICD), his symptoms persisted with swelling, dizziness, and severe fatigue. A heart transplant became the only life-saving option.
But the challenge was immense:
- HCM is rare and complex to manage.
- The waiting period for a donor heart was long and uncertain.
- The surgery itself demanded a highly skilled multidisciplinary team and cutting-edge surgical infrastructure.
A Second Chance at Life
Rafi’s journey with Manipal Hospitals spanned over a decade, marked by continuous monitoring, advanced interventions, and finally, a life-saving heart transplant.
1. Early Management and Long-Term Care
From the first signs of Hypertrophic Cardiomyopathy (HCM), Rafi was under the expert care of Dr. Sridhara G., Consultant – Interventional Cardiology & Cardiac Electrophysiology. His initial treatment plan focused on lifestyle adjustments, medications, and close follow-ups. For years, this medical management helped him sustain a near-normal life despite the progression of the disease.
2. Advanced Intervention – AICD Implantation
As his condition worsened and the risk of sudden cardiac arrest grew, Rafi underwent the implantation of an Automated Implantable Cardioverter Defibrillator (AICD). This device continuously monitored his heart rhythm and delivered life-saving shocks when irregular, potentially fatal rhythms were detected. While the AICD offered a safety net, it was only a temporary solution, and symptoms of fatigue, swelling, and reduced mobility continued to escalate.
3. The Wait for a Donor Heart
By 2019, Rafi’s heart had entered failure stage. The only definitive treatment was a heart transplant. He was placed on the transplant registry, joining thousands of patients in need of a donor organ. The wait was emotionally and physically draining—marked by uncertainty and the daily struggle of coping with end-stage heart failure. Despite this, the team at Manipal provided constant monitoring, emotional support, and medical stabilization to keep him strong enough for surgery when the opportunity arrived.
4. The Transplant Surgery
On March 21, 2025, hope arrived. A suitable donor heart became available. A multidisciplinary team led by Dr. Devananda N.S., HOD and Consultant – Cardiothoracic Vascular Surgery, and Heart & Lung Transplant Surgery, performed the highly complex transplant procedure. The surgery demanded precision, coordination, and hours of delicate work to remove the failing heart and replace it with the donor organ.
5. Post-Operative Recovery
Following the surgery, Rafi spent two weeks in the hospital’s advanced cardiac intensive care unit, where he received round-the-clock monitoring to prevent organ rejection and infections.
The post-operative plan included:
- Immunosuppressive therapy to help his body accept the donor heart
- Physiotherapy to gradually regain strength and mobility
- Nutritional guidance for healing and long-term heart health
- Psychological and emotional support for adapting to his new life
6. Road to Healing
Rafi was discharged on April 5, 2025, just two weeks after surgery. While his recovery will span another 3–4 months, his progress has been encouraging. For the first time in nearly two decades, he looks forward to living without constant fatigue and limitations.
Ending Thoughts
The story of Mohammed Rafi at Manipal Hospitals truly touches the heart, showing how a dedicated team leads the way in addressing genetic cardiac disorders with innovative yet deeply compassionate care—an approach we're now proudly extending worldwide to help close those daunting healthcare divides. We understand the fear, uncertainty, and emotional toll these conditions can bring to individuals and families, and by blending groundbreaking research (such as advancements in stem cell therapies and genetic databases) with truly patient-focused support, Manipal is committed to delivering hope and superior results for intricate cases from more than 100 countries.
Discover Real Patient Journeys Through In-Depth Medical Case Studies
